Does DURVALUMAB Cause Cholangitis? 157 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Cholangitis have been filed in association with DURVALUMAB (IMFINZI). This represents 0.9% of all adverse event reports for DURVALUMAB.
157
Reports of Cholangitis with DURVALUMAB
0.9%
of all DURVALUMAB reports
33
Deaths
55
Hospitalizations
How Dangerous Is Cholangitis From DURVALUMAB?
Of the 157 reports, 33 (21.0%) resulted in death, 55 (35.0%) required hospitalization, and 12 (7.6%) were considered life-threatening.
Is Cholangitis Listed in the Official Label?
Yes, Cholangitis is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Cholangitis?
NIVOLUMAB (389)
PEMBROLIZUMAB (357)
PACLITAXEL (289)
GEMCITABINE (225)
TACROLIMUS (213)
BEVACIZUMAB (176)
FLUOROURACIL (175)
OXALIPLATIN (147)
IRINOTECAN (146)
ATEZOLIZUMAB (145)
Which DURVALUMAB Alternatives Have Lower Cholangitis Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE